| Ali Stockstill, OT | |
|
1321 W Highway 8 Ste 4, Cleveland, MS 38732-2267 | |
| (662) 410-1440 | |
| (662) 410-1442 |
| Full Name | Ali Stockstill |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1321 W Highway 8 Ste 4, Cleveland, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376305383 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT2433 (Mississippi) | Primary |
| Provider Name | Performance Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851427132 PECOS PAC ID: 7012971047 Enrollment ID: O20041118000549 |
News Archive
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that its MagniFuse™ Bone Graft has generated its first $1 million in revenue during the four month period beginning with the limited launch of the product in late October 2009. Osteotech began the first phase of its strategic limited launch of MagniFuse with the release of three procedure specific forms for posterior cervical and posterolateral spine fusion and spinal deformity procedures.
In an Aug. 7 letter to Texas Health and Human Services Executive Commissioner Albert Hawkins, CMS official Dianne Heffron questioned whether the state's plan to overhaul Medicaid by providing subsidized health coverage to 2.1 million uninsured residents would move quickly enough and be broad enough to justify relaxing federal rules, the Dallas Morning News reports. Heffron wrote, "It appears that significant, comprehensive reform would not begin until September 2010."
A new study identified an adenovirus gene therapy vector carrying a VEGF isoform. It can improve uterine blood flow in placental insufficiency, as reported in the peer-reviewed journal Human Gene Therapy.
Results from a comprehensive multi-site clinical trial demonstrated that the use of antimicrobial copper surfaces in intensive care unit rooms reduced the amount of bacteria in the rooms by 97 percent and resulted in a 41 percent reduction in the hospital acquired infection rate.
Current treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ali Stockstill, OT 921 W Beacon St, Philadelphia, MS 39350-3229 Ph: (601) 650-0002 | Ali Stockstill, OT 1321 W Highway 8 Ste 4, Cleveland, MS 38732-2267 Ph: (662) 410-1440 |
News Archive
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that its MagniFuse™ Bone Graft has generated its first $1 million in revenue during the four month period beginning with the limited launch of the product in late October 2009. Osteotech began the first phase of its strategic limited launch of MagniFuse with the release of three procedure specific forms for posterior cervical and posterolateral spine fusion and spinal deformity procedures.
In an Aug. 7 letter to Texas Health and Human Services Executive Commissioner Albert Hawkins, CMS official Dianne Heffron questioned whether the state's plan to overhaul Medicaid by providing subsidized health coverage to 2.1 million uninsured residents would move quickly enough and be broad enough to justify relaxing federal rules, the Dallas Morning News reports. Heffron wrote, "It appears that significant, comprehensive reform would not begin until September 2010."
A new study identified an adenovirus gene therapy vector carrying a VEGF isoform. It can improve uterine blood flow in placental insufficiency, as reported in the peer-reviewed journal Human Gene Therapy.
Results from a comprehensive multi-site clinical trial demonstrated that the use of antimicrobial copper surfaces in intensive care unit rooms reduced the amount of bacteria in the rooms by 97 percent and resulted in a 41 percent reduction in the hospital acquired infection rate.
Current treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots.
› Verified 9 days ago
Mrs. Shannon Dixon Taylor, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4036 Highway 8, Cleveland, MS 38732 Phone: 662-843-4014 | |
Daty H Cooke, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4036 Highway 8, Cleveland, MS 38732 Phone: 662-843-4014 Fax: 662-843-5401 | |
Presley G Lee, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16 Gaston Dr, Cleveland, MS 38732 Phone: 662-843-2339 Fax: 662-846-1397 | |
Mrs. Julie Manning Price, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 712 N Chrisman Ave, Suite C, Cleveland, MS 38732 Phone: 662-843-3004 Fax: 662-843-0820 | |
Wesley W Radicioni, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 29 Earl Ave, Cleveland, MS 38732 Phone: 662-719-7129 |